Male, 35 y/o

Patient internal ID: 302683160

ICD-10 code

C16.2 Malignant Neoplasm of the Stomach Body.

Diagnosis (incl metastases/stage) and year

June 2020
Adenocarcinoma of Gastric Body cT3N1Mo G3 (ypT3N3a LV1 R0).

Previous treatment

Chemotherapy (FLOT4), Surgery (Gastrectomy) + HIPEC, Chemotherapy (Cisplatin + Fluorouracil).

Prognosis and survival expectation

The prognosis remains poor, with a median survival of ~40 months from diagnosis.

Treatment provided

Autologous DCV (7 doses) and CIK (9 doses) over a period of 6 months.

Patient survival/condition and year

Patient survived 21 months from diagnosis, he had reached a stable disease control, however, he died due to other medical complications. It can be concluded that Immunotherapy, alongside Chemotherapy, Surgery and HIPEC Chemotherapy, benefited for disease control.

Date of Review